Produces high-quality bulk drugs and intermediates.
Annual revenue $8.9M Latest available
Total funding - Funding intelligence
Employees 157 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Endoc Pharma

Endoc Pharma is a company based in Rajkot (India) by Suresh Sorathiya. It operates as a B2B. The company has 157 employees as of March 31, 2022. Endoc Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Rajkot, India
  • Employees 157 as on 31 Mar, 2022
  • Founders Suresh Sorathiya
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Endoc Lifecare Private Limited
  • Date of Incorporation 03 Apr, 2012
  • Jurisdiction Rajkot, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $8.94 M (USD)
    29.26
    as on Mar 31, 2022
  • Net Profit
    $1.13 M (USD)
    64.42
    as on Mar 31, 2022
  • EBITDA
    $1.68 M (USD)
    84.69
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    157

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Endoc Pharma

Investments & Acquisitions by Endoc Pharma

Investments

Financial Statements - Endoc Pharma

Endoc Pharma Comparisons

+
Add Comparison
Available on Premium

Competitors of Endoc Pharma

Endoc Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical and biotechnology company
domain founded_year HQ Location
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
domain founded_year HQ Location
APIs and drug products are developed and valorized in pharmaceuticals.
domain founded_year HQ Location
APIs, intermediates, and biochemical reagents are developed and manufactured.
domain founded_year HQ Location
APIs are developed and manufactured for therapeutic areas.
domain founded_year HQ Location
Contract development, manufacturing, and analytical services for APIs are offered.

Latest news on Endoc Pharma

Frequently Asked Questions about Endoc Pharma

Endoc Pharma is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.

As of Mar 31, 2022, the latest employee count at Endoc Pharma is 157.

Annual revenue of Endoc Pharma is $8.94M as on Mar 31, 2022.

Endoc Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs and intermediates. Produces high-quality bulk drugs and intermediates. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Endoc Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available